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from angiotensin blockade.2 In our 30-month prospective
analysis, in five of 103 patients with increasing azo-
temia while on RAAS blockade (AB), and no known
precipitating factors, mean serum creatinine improved from
2.970.9 to 1.870.4 mg/dl (P¼ 0.04), following discontinua-
tion of AB.2 One of the five patients, a 47-year-old white
woman, with hypertension and stable systemic lupus
erythematosus, was referred to us to start hemodialysis in
November 2002, with symptomatic uremia. Serum creatinine
was 4.3 mg/dl. After 40 months, following discontinuation of
lisinopril, she remains an active grandma and part-time
Secretary; current serum creatinine, 2.3 mg/dl (Figure 1).
Unrecognized microvascular renal artery stenosis was in-
voked as the underlying pathogenetic mechanism for our
observations.2
Furthermore, we reviewed the large clinical trials on AB.
Clearly, study guidelines/exclusion criteria such as patient
age, baseline serum creatinine, close monitoring of serum
creatinine, and dose of AB are not adhered to in general
practice.3
We submit that the escalating and sometimes uncontrolled
use of AB in general practice is a factor in the increasing end-
stage renal disease epidemic.1–4 A more cautious and prudent
application of AB, we submit, will serve renoprotection,
better.
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In his letter to the editor, Ring1 criticizes the validity of the
empirical relationship between the plasma water sodium
concentration ([Naþ ]pw) and total exchangeable sodium
(Nae), total exchangeable potassium (Ke), and total body
water (TBW) originally reported by Edelman et al.:2
½Naþpw ¼ 1:11ðNae þ KeÞ=TBW  25:6 ð1Þ
First, Ring criticizes the study of Edelman et al.2 in that the
measurements were not made in the steady state and that the
authors failed to measure Nae, Ke, and TBW simultaneously.
These criticisms are unfounded. We recently demonstrated
that the [Naþ ]pw is proportional to the ratio (NaeþKe)/
TBW at any given point in time because the body fluid
compartments are in osmotic equilibrium.3 As osmotic
equilibrium is attained very rapidly, it is irrelevant whether
the patient is in a steady state or not. Regarding the fact that
the measurements of Nae, Ke, and TBW were not performed
simultaneously, Edelman et al.2 were well aware of this and
the measured Nae was back corrected to the time of
determination of Ke and TBW by monitoring the metabolic
balance for Naþ during the period of Na24 equilibration.
This correction was applied to provide simultaneous
estimates of Nae, Ke, and TBW as Nae was measured 24 h
after the measurement of Ke and TBW.
2 Ring seems to have
missed this point.
Secondly, Ring faults the study of Edelman et al. from a
statistical perspective. He argues that the investigators failed
to take into account measurement errors in the x and y
variables in obtaining the regression relation between
y¼ [Naþ ]pw and x¼ (NaeþKe)/TBW described in equation
(1). This is an inaccurate assessment. Using the data (Tables
II and III) in the study of Edelman et al.,2 simple regression
analysis using [Naþ ]pw as the dependent variable yields the
following equation:
½Naþpw ¼ 0:93ðNae þ KeÞ=TBW þ 1:37 ð2Þ
Ring seems to be unaware the authors did recognize that
measurement errors in x (owing to measurement errors in
Nae, Ke, and TBW) would attenuate estimated correlation
coefficients, so that equation (2) would underestimate the
magnitude of the slope between true values of y and x.
Edelman et al.2 were specific in describing their method of
bias correction for correlation coefficients, and we have
verified that taking into account the analogous bias
correction for regression equation (2) yields results compar-
able to their final equation (1). We have also independently
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Figure 1 | GFR changes in a patient following discontinuation of
lisinopril.
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verified similar regression relations using more modern
statistical methods that take into account errors in x and y
variables. For example, Passing–Bablok regression analysis
yields a slope of 1.13 and a y-intercept of 28.1,4 which is in
excellent agreement with the bias-corrected slope and y-
intercept in equation (1).
One valid statistical concern that Ring did not raise is the
appropriateness of using simple regression analysis for the
cross-sectional data of Edelman et al., containing one data
point per individual, to infer the relationship between x and y
within any individual. A common assumption is that
equation (1) represents population estimates (i.e., that the
bias-corrected parameters are the mean slope and mean y-
intercept across individuals), but without replicate data
within the same individual this is impossible to verify.
In this regard, it is interesting to note that Edelman et al.2 did
have serial observations for three individuals for whom
changes in [Naþ ]pw and (NaeþKe)/TBW were followed
over a 5- to 7-week period. Based on their Table V, the
within slope estimates were 1.09, 1.14, and 1.03 for these
individuals. This is additional supportive evidence for slopes
greater than 1.0.
Ring also argues that ‘we cannot take as given that the
situation of our patients matches that studied by Edelman
et al.’ Contrary to what is stated by Ring, the 98 subjects
enrolled in Edelman’s2 study represent a very diverse patient
population. Specifically, the enrolled subjects include patients
with heart disease, liver disease, kidney disease, pulmonary
disease, gastrointestinal disease, neurological disease, and a
miscellaneous group of clinical disorders. Therefore, the
study subjects are representative of a diverse patient
population with dysnatremias.
Ring stated that the ‘unpretentious form of Rose5 (slope 1,
intercept 0) may well encapsulate all we can know at present’.
In other words, Ring holds the belief that the relationship
between the [Naþ ]pw and Nae, Ke, and TBW is represented
by the simplified equation:5
½Naþpw ¼ ðNae þ KeÞ=TBW ð3Þ
If equation (3) models human physiology accurately, then
only changes in the mass balance of Naþ , Kþ , and H2O will
result in a change in the [Naþ ]pw in our patients. However as
is widely known, equation (3) must be incomplete as it
cannot account quantitatively for all the causes of the
dysnatremias resulting from factors that do not alter the
value of the (NaeþKe)/TBW term. These factors include: (1)
changes in the [Naþ ]pw owing to inter-compartmental water
shifts in hyperglycemia, and owing to osmoles such as
mannitol, sucrose, maltose, and contrast agents;6–12 (2)
transcellular shifts of Naþ and Kþ in hypokalemia-induced
hyponatremia;13,14 and (3) a component of the Nae and Ke is
osmotically inactive and incapable of modulating the
[Naþ ]pw.
15–17
Ring takes the view that the uncertainty in the data of
Edelman et al.2 justifies assigning a value of 1 and 0 to the
slope and intercept respectively. It is not clear to us why these
values are more justified than the values reported by Edelman
et al.,2 unless Ring believes that simplicity per se is a valid
criterion for basing his conclusions in lieu of the statistical
approach used by Edelman et al.2 In addition, Passing–Bablok
regression analysis yields a 95% confidence interval of 7.81
to 56.7 for the y-intercept,4 which tends to reject a
population intercept of zero under the assumption men-
tioned previously. Moreover, there are theoretical and
physiologic considerations independent of the empirical data
in Edelman’s study, which support Edelman et al.2 that the
slope is greater than unity and the y-intercept must have a
non-zero value that Ring seems to be unaware of. Specifically,
we have previously demonstrated that the slope is determined
physiologically by the combined effects of Gibbs–Donnan
equilibrium and the osmotic coefficient of Naþ salts.3 As a
result, the slope must be greater than unity.3 In fact, given the
known values of the osmotic coefficient of Naþ salts and the
Gibbs–Donnan ratio for the distribution of Naþ ions
between the plasma and interstitial fluid in humans, the
slope must be 1.11.3 This remarkable concurrence with the
data of Edelman et al.2 cannot be ignored. In addition, given
that the ratio of (NaeþKe)/TBW is significantly greater than
the [Naþ ]pw
2 and that the slope must be greater than unity
physiologically,3 the value of the y-intercept must have a non-
zero value. Using independent measurements of the con-
centration of the total body solutes reported by Guyton and
Hall,18 the y-intercept in the Edelman equation has a value of
B25 mEq/l.19 Therefore, Ring’s assertion that equation (3)
‘(slope 1, intercept 0) may well encapsulate all we can know
at present’ not only is not supported by physiological and
clinical data but also is incorrect based on theoretical
principles that govern certain factors that modulate the
distribution of Naþ .
We fully agree with Ring that the 11 new equations19
derived to analyze and treat the dysnatremias are mathema-
tical extensions of equation (1).2 However, we disagree with
Ring’s implication that the data of Edelman et al.2 cannot be
considered ‘real experimental work’. As these new equations
are derived on the basis of the experimental work of Edelman
et al., the validity of these equations is indeed empirically
grounded.
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I wrote a letter to ask Kurtz and Nguyen1 to specify how
accurate their assessment of the equation [Naþ ]pw¼
1.11(NaeþKe)/TBW25.6 and its proposed augmentations
could possibly be: intervals of confidence for slope and
intercept. If these are undefined, I would assume that the
many equations could not be distinguished in clinical
practice, including the one with intercept¼ 0 and
slope¼ 1. The authors do not seem to know an answer to
that question. Boling and Lipkind provided an analysis of
the intercept measurement in the Edelman paper similar to
what I did, based on the original values and wrote: ‘ythe
degree of certainty regarding the magnitude of this
constant term is not great; the origin of regression lies
within the 99% confidence limits for the regression line,
and the 95% confidence limits (at X¼ 0) are 5.2 and
45.8’.2 I had 5.2 and 46.0 with present-day software.
As Edelman and co-workers described, this equation was
obtained by careful assessment of a great number of
patients by isotopic dilutions. These dilutions are not
simple, requiring 40 h for K and 24 h of observation for Na
(probably explaining that they were not frequently
performed in recent times) and the problem of knowing
when equilibrium is reached certainly is not straight-
forward and necessarily mixes with subtle definitions of
osmotically active and inactive moieties. The suggestion
that osmotic balance is rapidly attained is not contested,
but steady state must be of interest when assessing the
exchangeability of electrolytes during 40 h of equilibrium.
Recent experimental studies arguing about the status of
osmotic inactivation and also observations from sports
medicine show that quite large amounts of Na and
K can behave unpredictably.3–5 Hence, even though the
authors cite a number of situations wherein they have
difficulties in understanding [Na], I cannot see how they
conclude that a and b in [Naþ ]pw¼ a(NaeþKe)/TBWb are
primarily to fault when (NaeþKe)/TBW are not measured
in any of these studies.
I certainly agree with the authors that the work of
Edelman et al. was second to none, and really wrote my letter
to ask for more of that kind instead of math work. Edelman
et al. carefully specified the uncertainty of the estimates, as
I wrote, and even gave the individual data (from which, by
the way, it can be verified that minor miscalculations
occurred in patient numbers 25 and 37 (heart disease) – but,
rest assured, removing them changes nothing). However, a
complicated thing such as measuring deuterium enrichment
has changed during the years, and the falling drop method as
used by Edelman et al. has since been surpassed.6 It is true
that Edelman et al. made a correction for imprecision in
measurements to augment the correlation coefficient, but it
is wrong as stated by Kurtz et al. in their original paper that
this bears directly over to the regression – which was carried
out simply by least squares. The authors are right, however,
that uncertainty attenuates the regression, but I doubt it is
easy to say by how much. One of the most important
determinants will be the spread in independent values –
which is quite large in the original Edelman data, as
mentioned by Boling et al.1 The Passing–Bablok regression,
now introduced by Kurtz et al. was described in 1983 and
not mentioned by Edelman in 1958 (which was the
question). However, Kurtz et al. may well be right that the
true slope in [Naþ ]pw¼ a(NaeþKe)/TBWb often is more
than 1 and the intercept often different from 0. The issue was
if 11 new equations were separable, however. It is true that to
all this must be added problems of individual patient frailty
and autocorrelations between repeated measurements in
each patient and more. I did not miss the point, that
Edelman made a brilliant cross-sectional study. This only
further strengthens the demand for data rather than
speculation when trying to untangle this difficult subject.
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